Deciphera Raises $150M Via Equity Offering

• Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) has priced an underwritten public offering of 5.25 million shares at $10.00 per share, for gross proceeds of $150 million.
• The offer price represents a discount of 3.5% from the last close price of $10.36 on Tuesday.
• In addition, Deciphera is offering pre-funded warrants to purchase 9.75 million common shares at $9.99 per pre-funded warrant.
• Underwriters have an option to purchase up to an additional 2.25 million shares.
• Related: Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies.
• The offering is expected to close on April 29.
• Deciphera will use the net proceeds to continue funding the development of vimseltinib, DCC-3116, the pan-RAF program and other new research activities, and the remainder for working capital purposes.
• Price Action: DCPH shares traded 3.47% lower at $10.00 during pre-market trading on Wednesday.